Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ADMA and oxidative stress.

Karsten Sydow1, Thomas Münzel

  • 1Falk Cardiovascular Research Center, Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA. ksydow@cvmed.stanford.edu

Atherosclerosis. Supplements
|December 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19-A Large Postmortem and Clinical Analysis.

Viruses·2022
Same author

Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2020
Same author

Adherence to Mediterranean diet, high-sensitive C-reactive protein, and severity of coronary artery disease: Contemporary data from the INTERCATH cohort.

Atherosclerosis·2018
Same author

Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort Study.

Clinical therapeutics·2017
Same author

Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System.

Frontiers in cardiovascular medicine·2017
Same author

Transcatheter aortic valve implantation with the new-generation Evolut R™: Comparison with CoreValve® in a single center cohort.

International journal of cardiology. Heart & vasculature·2017
Same journal

'Diet and lifestyle' in the management of dyslipidaemia and prevention of CVD - Understanding the level of knowledge and interest of European Atherosclerosis Society members.

Atherosclerosis. Supplements·2021
Same journal

Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool.

Atherosclerosis. Supplements·2021
Same journal

Lipid Clinics Network. Rationale and design of the EAS global project.

Atherosclerosis. Supplements·2021
Same journal

Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives.

Atherosclerosis. Supplements·2021
Same journal

Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project.

Atherosclerosis. Supplements·2021
Same journal

Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies.

Atherosclerosis. Supplements·2021
See all related articles

Elevated asymmetric dimethylarginine (ADMA) levels are linked to endothelial dysfunction and increased mortality. This study explores if high ADMA directly causes vascular disease by increasing oxidative stress and affecting nitric oxide synthase.

Area of Science:

  • Cardiovascular Research
  • Endothelial Function
  • Oxidative Stress

Background:

  • Elevated asymmetric dimethylarginine (ADMA) is a risk factor for endothelial dysfunction and mortality.
  • The role of ADMA as a direct cause versus a marker of vascular disease is unclear.
  • Endothelial dysfunction is associated with increased superoxide anion production and oxidative stress.

Purpose of the Study:

  • To investigate whether elevated ADMA levels directly contribute to vascular disease development.
  • To explore the mechanisms linking ADMA to oxidative stress.
  • To examine the interaction between ADMA and endothelial nitric oxide synthase (eNOS) in vivo.

Main Methods:

  • Review of experimental and clinical evidence linking endothelial dysfunction, oxidative stress, and ADMA.

Related Experiment Videos

  • Analysis of how oxidative stress influences ADMA metabolism (synthesis and degradation).
  • Discussion of potential mechanisms of ADMA interaction with eNOS.

    • Main Results:

    • Oxidative stress can increase ADMA concentrations by affecting related enzymes.
    • High ADMA levels may lead to eNOS uncoupling, exacerbating vascular oxidative stress.
    • The precise in vivo interaction between ADMA and eNOS requires further elucidation.

    Conclusions:

    • Elevated ADMA may actively promote vascular disease through oxidative stress mechanisms.
    • Understanding ADMA-eNOS interactions is crucial for potential therapeutic strategies.
    • Further research is needed to confirm the direct causative role of ADMA in vascular disease.